Family SuppleMented pAtient monitoRing afTEr suRgery: A Pilot Trial

NCT04341558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1395

Last updated 2022-09-09

No results posted yet for this study

Summary

To develop an intervention to train family carers to perform and document basic vital signs whilst they provide personal care to their relatives after surgery in order to supplement patient monitoring conducted by nursing staff. To evaluate the effect of this intervention on the frequency of documented vital signs for patients in the first three days after surgery in a stepped-wedge cluster trial.

Conditions

  • Postoperative Care
  • Vital Signs

Interventions

OTHER

Family supplemented patient monitoring

Intervention training sessions will last 30 minutes and will be held twice a day over a period of six months. Carers will be welcome to attend as often as they wish. Carers will be given practical training to assess the following vital signs: heart rate, respiratory rate, conscious level (AVPU scale) and arterial oxygen saturation (SpO2) in accordance with trial standard operating procedures. An important component of the training package will be ensuring carers know how to wash their hands before and after contact with their patients. The study team will ensure that handwashing facilities are available on the ward for use by carers. Carers will record vital signs on a basic observation chart every 4 hours after surgery. They will compare results with colour posters displayed throughout each ward, providing guidance on how and when to notify nursing staff of abnormal vital signs.

Sponsors & Collaborators

  • Busitema University

    collaborator OTHER
  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Rupert Pearse, MD · Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-13
Primary Completion
2021-10-12
Completion
2021-11-12

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341558 on ClinicalTrials.gov